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Background and Objective: Low level laser therapy (LLLT) has been developed for non-
invasive treatment of joint diseases. We have previously shown that LLLT influenced 
synovial protein expression in rheumatoid arthritis. The aim of this study was to assess the 
effects of laser irradiation on osteoarthritic (OA) synovial protein expression.  
 
Study Design/Materials and methods: The synovial membrane samples removed from the 
knees of 6 OA patients were irradiated ex vivo using near infrared diode laser (807-811 nm; 
25 J/cm2). An untreated sample taken from the same patient served as control. Synovial 
protein separation and identification were performed by two-dimensional differential gel 
electrophoresis and mass spectrometry, respectively. 
 
Results: Eleven proteins showing altered expression due to laser irradiation were identified. 
There were three patients whose tissue samples demonstrated a significant increase (p<0.05) 
in mitochondrial heat shock 60kD protein 1 variant 1. The expression of the other proteins 
(calpain small subunit 1, tubulin alpha-1C and beta 2, vimentin variant 3, annexin A1, 
annexin A5, cofilin 1, transgelin and collagen type VI alpha 2 chain precursor) significantly 
decreased (p<0.05) compared to the control samples.  
 
Conclusions: A single diode laser irradiation of the synovial samples of patients with 
osteoarthritis can statistically significantly alter the expression of some proteins in vitro. 
These findings provide some more evidence for biological efficacy of LLLT treatment, used 
for osteoarthritis.  
 
Key words: ex vivo, laser therapy, proteomics, synovial membrane  
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Studies of the expression of proteins (proteomics) play a more and more important role in the 
investigation of various clinical entities (1). This technique has been successfully used in 
studying the expression of cytosolic proteins of the synovial membranes in rheumatoid 
arthritis (RA), osteoarthritis (OA) and ankylosing spondylitis (AS). Differences were found in 
the protein expression of calgranulin A, vimentin, α-enolase, fructose biphosphate aldolase A 
in the synovial membrane of patients with RA and AS compared to OA (2). The identification 
of new biological and clinical markers of inflammatory rheumatic diseases (RA, AS) opened 
new possibilities of further dissecting the synovial effects of low level laser therapy (LLLT) 
(3). Bjordal et al. (4) proved the anti-inflammatory and pain-relieving effects of LLLT in the 
infrared wavelength range in Achilles tendinitis in a randomized, placebo controlled study. 
Several authors have reported the beneficial clinical results of LLLT in OA and tendinopathy 
(5). In in vitro studies LLLT decreased inflammation by diminishing the production of PGE2 
and by inhibiting cyclo-oxigenase 2 (6-13). Rizzi et al. (14) showed that LLLT reduced the 
inflammatory response induced by trauma in animals by blocking the effects of reactive 
oxygen species (ROS) and the activation of nuclear factor kappa B (NFκB). Bo et al. (15) also 
suggested the importance of proteomics in understanding disease pathogenesis in arthritides 
and in identifying new therapeutic targets. Finally, we have recently showed that the 
expression of some proteins in the rheumatoid synovial membrane significantly changed 
following laser irradiation (16).  
In the present study we wished to determine whether the expression pattern of 
synovial proteins in OA would be affected by ex vivo laser irradiation.  
 
Patients and methods 
Patients 
 
Synovial samples of six patients with knee OA, according to American College of 
Rheumatology (ACR) classification criteria, were studied. The clinical and laboratory 
characteristics of our patients are shown in Table 1. 
 
Sample preparation and protein extraction 
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Following surgery, OA synovial membrane samples were immediately placed into Medium 
199 (Sigma Aldrich) solution at 4 ºC. First the fatty and connective tissues were removed, 
then two 0.5 cm2 pieces from the macroscopically identical, adjacent parts of synovial 
membranes were excised. For the in vitro irradiation of synovial membrane samples, an 
approximate mean radiant exposure of 25 J/cm2 was chosen to model real exposure during 
clinical treatment (16). Half of the samples were irradiated by laser at distance of 8 cm from 
the aperture in Petri dishes containing M199 medium. The irradiated area was about 1 
cm2.The control samples were kept under identical conditions, but were not irradiated. Laser 
irradiation was carried out using a KLS-500 type diode laser (Laseuropa Ltd, Budapest, 
Hungary), a laser instrument similar to ones used in clinical practice of the authors. The 
parameters of the laser were as follows: wavelength: 807-811 nm; power: 448 mW; output 
aperture size: 2 mm x 4.5 mm; beam divergence: 5º. Following irradiation, the samples were 
incubated at 37 ºC for 21 hours in M199 medium in a 5 % CO2 thermostat (Heto-Holten). The 
samples were stored at -70 ºC until further use. In order to extract proteins, the frozen samples 
were homogenized using a homogenizer (Janke&Kunkel Ika-Werk Ultra Turrax) on ice in 
300-300 µl lysing buffer (7 M urea, 2 M thiourea, 30 mM Tris, 4 % CHAPS, pH 8.5). The 
solution underwent ultrasound treatment for 1 minute (Bandelin Sonorex TK52) then it was 
centrifuged (12,000 g, one hour, 4 ºC). The proteins in the supernatant were precipitated by 
acetone (1:4 v/v), then they were centrifuged (3,000 g, 10 minutes, 4 ºC). The protein samples 
were stored in a lysing buffer at -20 ºC until analytical processing.  
 
Separation of proteins by two-dimensional differential gel electrophoresis (2D-DIGE) 
 
The pH of protein samples was set at 8.0 and then the protein concentration of the 
samples was determined using PlusOne Quant Kit (GE Healthcare Hungary, Budapest) 
according to manufacturer’s protocol. From each sample, 5 µg of proteins were labelled with 
CyDye DIGE Fluor Labelling kit for Scarce Samples (GE Healthcare) dye (4 nmol of dye / 5 
µg of proteins) according to protocol. Samples containing 2.5 µg of proteins from each control 
and each laser-treated sample got into the pooled (internal standard) sample. This pooled 
sample was labelled by Cy3, whereas the control and the treated samples were labelled by 
Cy5. Then the two differently labelled samples (5 µg of samples and 5 µg of pooled samples 
labelled by Cy5 and Cy3, respectively) were mixed. Next, 2 mg/ml ditio-treitol (DTT) and 5 
µl/ml of IPG buffer were added fresh to our buffer (8 M of urea, 4 v/v% of CHAPS, 15 v/v% 
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of glycerine), the mixed samples were completed to 450 µl. The samples were then rehydrated 
on 24 cm IPG strips (pH 3-10 NL, GE Healthcare) for 14 hours at room temperature. 
Rehydration was followed by the isoelectric focusing of the proteins for 23.5 hours using 
Multiphore II (GE Healthcare) equipment. The settings were the same as reported previously 
(16). After this the focused proteins were reduced with / in an equilibrated solution for 20 
minutes (1.5 M of Tris, 6 M of urea, 30 % of glycerine, 20 % of sodium dodecyl sulphate 
(SDS), 0.1 % of bromide-phenol blue, 1 µl/ml of mercaptoethanol), then the strips were 
placed on SDS polyacrylamid gels of 10 % and were fitted with agar solution of 0.5 %. The 
gels were run in running tubs filled up with running buffers (Ettan Dalt Six, GE Healthcare) 
with of the following parameters: 60 minutes, 18 ºC, 2 W/gel; then: 6 hours, 18 ºC, 12 W/gel. 
At the end of running the gels were scanned by Typhoon TRIO + device at a wavelength 
corresponding with the applied CyDye dyes. The scanned pictures were evaluated with the 
DIA (DeCyder Differential Image Analysis) and BVA (DeCyder Biological Variation 
Analysis) programs. The protein spots were identified in which the amount of proteins were 
significantly different (p<0.05) in th  treated sample compared to the control.  
 
Protein identification using preparative gel and data analysis 
 
Protein samples of 800 µg were added to the preparative gel. During the first 
dimensional run the protocol corresponding to the analytical gel was applied. Deviation 
occurred just at the second dimensional run. The glass sheets used for preparing the gel had 
been treated with Blind Silane solution (ethanol: 80 %, ice vinegar acid: 0.02 %, blind silane: 
0.001 %, ddw: 18 %). After the run, the gels were fixed for an hour (20 % of methanol, 1 % 
of phosphoric acid), then they were dyed using methanol:A:B=2:8:1 solution. (Solution A: 0.3 
M of ammonium-sulphate, 2.4 % of phosphoric acid; solution B: 5 % of Coomassie Blue G-
250) for one week. Then gels were neutralized using Tris-solution of 0.05 M (pH 6.5) for 3 
minutes, then it was washed with methanol of 25 %, finally it was stabilized by ammonium-
sulphate of 0.75 M for 8 hours. Based on the results of the analytical gel, the identical protein 
spots of the preparative gel were excised. These were evaluated in the Department of 
Chemistry at University of Szeged by liquid chromatography-mass spectrometry (LC-
MS/MS) analysis. For the identification of proteins the following criteria were used: protein 
score > 66 (see Table 2) and level of significance of p<0.05 were considered as significant.  
 
Results 
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Altogether 11 proteins exerted differential expression in LLLT reated OA synovial 
tissue samples as compared to untreated control samples (Table 2).  
 Mitochondrial heat-shock 60kD protein 1 variant 1 (mhsp60) was the only protein 
showing significantly increased expression in synovial tissue of three patients following 
LLLT compared to untreated synovial tissue (p<0.05).  
 Other synovial proteins, such as calpain small subunit 1, tubulin alpha-1C and beta 2, 
vimentin variant 3, annexin A1, annexin A5, cofilin 1, transgelin and collagen type VI alpha 2 
chain precursor exerted significantly lower expression in OA synovium of at least three 




 The clinical efficacy of LLLT in various arthritides including OA has been 
established. However, little is known about the exact molecular effects of laser irradiation. 
Some research groups have used gel electrophoresis and MS proteomic techniques to compare 
the composition of healthy and OA cartilage. Garcia et al. (17) studied the components of OA 
chondrocytes and extracellular matrix (ECM) by MS method. Several proteins involved in 
ECM organisation, signal transduction, cell communication, immune responses and 
metabolism showed differential expression. Kirsch et al. (18) showed the expression of 
alkaline phosphatase, annexin II and type VI type collagen in the upper zone chondrocytes of 
human OA cartilage, but none of these in healthy human cartilage. 
 Here we present only those proteins that exerted significantly increased or decreased 
expression upon LLLT.  
 Our results show increased expression of mhsp60 in OA synovial membrane after 
LLLT compared to untreated controls. This protein belongs to the hsp60 (chaperonin) family 
(19-21). Tsan et al. (22) consider hsp-s as molecular chaperons recognizing and bounding 
polypeptid chains, and the partly-folded intermediates of proteins. Hsp-s inhibit aggregation, 
erroneous folding and directly mediate protein folding as chaperons. Yokota et al. (23) 
showed that anti-hsp60 antibody levels are higher in autoimmune diseases, such as 
rheumatoid arthritis, SLE, Sjögren’s syndrome and mixed connective tissue disease compared 
to healthy controls. Sedlackova et al. (24) suggested that the expression profile of hsp60 gene 
might serve as a new marker in the differential diagnosis between RA and OA. Hsp gene 
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expression profiles may be very different in inflammatory (RA) and non-inflammatory (OA) 
joint diseases.  
 Some other proteins showing diminished synovial expression after LLLT including 
calpain small subunit 1. This is a calcium-dependent cystein protease formed in the cartilage 
and synovial tissue. RA and OA chondrocytes actively secrete calpain and calpain levels are 
increased in both RA and OA synovial fluids compared to normal controls (25, 26). 
Whiteman et al. (27), as well as Squier et al. (28) described peroxynitrite (ONOO-)-mediated, 
calcium-dependent mitochondrial dysfunction and apoptosis caused by calpain activation. 
Szomor et al. (29) found that in murine collagen-induced arthritis (CIA) calpain expression 
correlated with the severity of inflammation and cartilage destruction. In an early phase of 
CIA calpain acts as a matrix proteinase and plays a role in enzyme activation and cartilage 
destruction. Although calpain is regarded as an intraarticular enzyme, recently calpain has 
also been detected in the site of callus formation after the fracture of growing cartilage (30), 
as well as in synovial fluids of OA patients (31). Solau-Gervais et al. (32) compared the 
activities of cystein proteases and dipeptidyl peptidase in synovial tissues of RA, OA and 
posttraumatic arthritic patients. Calpain activity was higher in RA and OA compared to 
posttraumatic controls. Struglics et al. (33) suggest that calpain plays a role in the cleavage of 
human aggrecan. Calpain-generated fragments were detected in both normal and OA cartilage 
and synovial fluids. Iguchi-Hashimoto et al. (34) described the overexpression of calpastatin, 
a calpain antagonist in arthritis. Calpastatin supresses IL-6 production, as well as NFκB 
signalling in RA. As calpain is highly involved in cartilage destruction and its expression 
decreased by laser irradiation, thus LLLT may diminish calpain-mediated degradation in OA.  
 Actin and tubulin are cytoskeletal proteins. Tubulin is a member of the family of 
globular proteins and is a constituent of microtubules. The expression of α-tubulin 
significantly decreased in all synovial tissue samples following LLLT. Ramos-Ruiz et al. (35) 
found suppressed tubulin synthesis in the synoviocytes of rats with adjuvant arthritis. The 
inhibition of tubulin synthesis may be an initial step in the development of adjuvant arthritis. 
The expression of cofilin was also reduced by LLLT in two synovial samples in our 
study. Campbell et al. (36) found that cofilin expression was significantly upregulated in 
chondrocytes upon mechanical stress. Rollin et al. (37) performed differential proteomic 
investigation of chondrocytes in OA patients. The expression of cytoskeletal binding proteins 
including cofilin and annexin 2 significantly increased in OA chondrocytes. Blain et al. (38) 
described a 3-dimensional network of cytoskeletal tubulin and intermediate filaments. Tubulin 
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and cofilin are involved in cytoskeleton formation and also in remodelling and mechanical 
properties of the cartilage. 
 Vimentin variant 3 expression was significantly reduced after LLLT in the synovial 
samples of three OA patients. Haudenschild et al. (39) reported that the changes in the 
organisation of vimentin correlates with the progression of OA, but the results of these 
changes, especially in chondrocytes are not clear. In their differential proteomic analysis of 
normal and OA chondrocytes, Lambrecht et al. (40) discovered that the vimentin network is 
severely impaired in OA. The organization of split vimentin was described in OA 
chondrocytes. Tilleman et al. (41) studied the cleavage of a citrullinated vimentin isoforms in 
OA cartilage. Similarly to Haudenschild et al. (39), this group found that the disruption of 
vimentin network weakened the mechanical integrity of cells. Wang et al. (42) observed that 
in numerous cell types, the loss of vimentin led to impaired DNA synthesis and cell 
proliferation. Tilleman et al. (43) concluded: „It could be possible, that a higher expression of 
vimentin contributes to the invasive character of the synovial pannus like tissue in 
inflammatory arthritides”. Therefore we may suppose, that laser induced decrease of vimentin 
variant 3 could be antiinflammatory and therefore beneficial in OA. 
 Ea et al. (44) reviewed the role of annexin A5 in OA. Biphasic calcium phosphate 
(BCP) and hydroxy-apatite (HA) crystals are associated with severe forms of OA. In severe 
OA, chondrocyte apoptosis is associated with the overexpression of annexin V and BCP 
crystal deposition in the matrix. It was demonstrated that the overexpression of annexin V 
may contribute to hypocellularity of the articular cartilage. The reduction of annexin V 
expression by LLLT treatment may lead to decreased chondrocyte apoptosis in OA. 
 We observed a significant decrease in the expression of collagen type VI alpha 2 chain 
precursor in five OA synovial samples following laser treatment. Hambach et al. (45) 
demonstrated severe abnormalities in the expression and distribution of pericellular collagen 
VI in OA. When comparing healthy and OA cartilage, the three chains of collagen VI were 
abundantly expressed in healthy articular cartilage, while collagen VI expression was 
significantly reduced in the superficial layer of the cartilage in OA. The authors concluded 
that the underexpression of collagen VI in the cartilage may result from increased degradation 
rather than by a decreased synthetic activity. Murray et al. (46) suggested that in OA the 
disruption of pericellular collagen VI was associated with increased production of IL-1β. 
Thus, the decrease in collagen VI expression induced by LLLT might be advantageous 
regarding chondrocyte metabolism. 
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 In conclusion, the significant increase in the expression of mhsp60 after LLLT 
treatment of OA synovial samples suggests the existence of a reparation process that inhibits 
protein aggregations and protein misfolding. The decreased expression of calpain small 
subunit 1, annexin A5, vimentin variant 3 and collagen type VI alpha 2 chain precursor 
expression after LLLT may result in the suppression of cartilage degradation in OA. Our 
study provided additional evidence for the molecular effects of LLLT in rheumatic diseases. 
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Table 1 Clinical and laboratory parameters of our patients 
 
Patient No.         Age (years) Disease 
duration (years) 
NSAID treatment 
1 76 5 + 
2 54 4 + 
3 74 5 + 
4 73 20 + 
5 57 3 - 
6 79 5 + 
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Table 2 Proteins showing significantly altered synovial expression upon laser irradiation  
 
Identification 
number of spot 
Score of 
protein shots 
Mass of protein 
molecule (kDa) 
NCBI ID* Identified protein 
1830 144 28 4502565 calpain small 
subunit 1  
1100 132 61 189502784 mitochondrial heat 
shock 60kD 
protein 1 variant 1 







tubulin beta 2 
vimentin variant 3 
1803 92 39 4502101 annexin A1 









581 94 110 13603394 collagen type VI 
alpha 2 chain 
precursor 
(* National Center for Biotechnology Information, identification number of the protein at the National Center for 
Biotechnology (USA))   
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Table 3  Treated/untreated expression rates of synovial proteins 
 
Identification 










         1830 calpain small 
subunit 1  
                       4 
                       2 
                       1 
                  0.78 
                  0.79 
                  0.67 
 
 
                 0.75 
         1100 mitochondrial 
heat shock 60kD 
protein 1 variant 
1 
                       2 
                       3 
                       5 
                  6.31 
                  2.00 
                  2.99 
 
 
                 3.77 
         1486 tubulin alpha-1C                        6 
                       5 
                       4 
                       3 
                       2 
                       1 
                  0.92 
                  0.87 
                  1.02 
                  0.94 
                  0.84 






                 0.88 
         1599 tubulin beta 2 
vimentin variant 
3 
                       5 
                       3 
                       2 
                  0.58 
                  0.11 
                  0.09 
 
 
                 0.26 
         1803 annexin A1                        5 
                       2 
                       6 
                       3 
                       1 
                  0.89 
                  0.90 
                  0.78 
                  0.81 





                 0.85 
         1655 annexin A5                        2 
                       3 
                       1 
                       4 
                  0.85 
                  0.58 
                  0.75 




                 0.74 
         1923 cofilin 1  
transgelin 
                       2 
                       3 
                  0.74 
                  0.78 
 
                  0.76 
           581 collagen type VI 
alpha 2 chain 
precursor 
                       1 
                       5 
                       3 
                       2 
                       6 
                  0.82 
                  0.71 
                  0.77 
                  0.60 





                  0.72 
* Only  those patients are indicated in whom there was a significant change ( p < 0.05)  upon 
laser irradiation . 
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